Management and other administrative services to the Medical Corporation. These services include billing, collection of accounts receivable, accounting, management and human resource functions.
The Company’s revenues earned from sale of products and services for the three months ended March 31, 2026 included 99 % from two customers of the Company’s total revenues.
The consolidated financial statements include the accounts of: (i) BioCorRx Inc. and its wholly owned subsidiary, Fresh Start Private, Inc., (ii) its majority owned subsidiary, BioCorRx Pharmaceutica…
to customers. The distribution rights income consists of the income recognized from the amortization of distribution agreements entered into for its products. The membership/program fees are generate…
BioCorRx Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
BICX-DEBT
Debt stack $2.1M
90%
Market cache reports total debt of $2.1M.
BICX-DEBT-8191
Warrants outstanding: 0.35
90%
xbrl warrant detail from xbrl 2025-07-29.
BICX-DEBT-8192
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
BioCorRx Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for BioCorRx Inc..
BioCorRx Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for BioCorRx Inc..
BioCorRx Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.